| |
|
|
|
Harvard Bioscience Inc.  
|
|
3.2794 -0.121 (-0.04%) |
12-14 15:21 |
|
Open: |
3.39 |
Pre close: |
3.4 |
Target:
|
4.54
|
|
High: |
3.51 |
Low: |
3.26 |
Resistance:
|
3.88
4.24
|
|
Volume: |
46,135 |
Market Cap: |
122M |
Support:
|
3.31
2.75
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
3.43
 |
MACD |
MACD(12,26):
|
-0.18 |
|
MA(20): |
3.67 |
Signal(12,26,9): |
-0.17 |
|
MA(100): |
4.87 |
Stochastic Oscillator |
%K(14,3):
|
10.24  |
|
MA(250): |
4.80 |
%D(3): |
10.08 |
|
Average Volume(K) |
3-Month: |
11268
|
52-Week |
High:
|
6.70 |
|
10-Days: |
4930 |
Low: |
3.10 |
|
RSI |
RSI(14):
|
31.84 |
Change(%): |
0.7 |
|
Financials, Statistics and Valuation |
|
EPS |
0.120 |
Return on Equity (ttm) |
-6.1 |
Shares Out. (M) |
37.29 |
|
EPS Est. Current Year |
0.130 |
Return on Assets (ttm) |
-3.5 |
Shares Float (M) |
29.67 |
|
EPS Est. Next Year |
0.170 |
PEG Ratio |
1.97 |
% Held by Insiders |
21.90 |
|
EPS Est. Next Quarter |
0.040 |
Qtrly Rev. Growth |
53.0 |
% Held by Institutions |
94.50 |
|
Forward EPS |
0.260 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
0 |
|
Book Value (p.s.) |
1.710 |
EBITDA (p.s.) |
0.000 |
P/E |
28.13 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
1.97 |
|
Profit Margin |
-4.06 |
Operating Cash Flow
(M) |
-0.65 |
P/S |
33922844.00 |
|
Operating Margin |
2.97 |
Levered Free Cash Flow
(M) |
8.86 |
P/CF |
-194.24 |
|
|
|
|
|
|
